Search

OBJECTIVE To identify the effect of the presence of a ureteric stent on the outcome of extracorporeal shockwave lithotripsy (ESWL), by comparing patients with ureteric stones with matched-pair analysis. PATIENTS AND METHODS Patients undergoing ESWL with the Sonolith Vision lithotripter (Technomed Medical Systems, Vaulx-en-Velin, France) were identified from our prospectively maintained database. Only adult patients with a solitary, radio-opaque, previously untreated ureteric stone were considered for further analysis. A follow-up of ≥3 months with a plain abdominal film was used to identify residual fragments. Patients were exactly matched for gender, side, location in the ureter and size (in two dimensions, within ±2 mm). If both diameters could not be matched exactly, the size was extended to ±1 mm and then to ±2 mm of both diameters. An effort was finally made to match patients by age. The treatment outcome in terms of stone-free rates was assessed and compared using McNemar’s test. RESULTS In all, 45 patients with a ureteric stent in place during ESWL were identified. The only patient who could not be adequately matched was a 40-year-old man with an 8 × 3 mm stone in the upper ureter. The best/closest match for age was selected. Most stones were in the upper ureter (77%); the mean stone size was 8.5 and 8.6 mm, respectively, with no statistical differences between the groups for age and size of stones ( P = 0.41 and 0.86, Student’s t-test). In 12 pairs, only patients with no stent were stone-free, compared to two pairs where the patient with a stent was stone-free. Using McNemar’s test, the odds ratio was 6.0 (95% confidence interval 1.3–55.2) and the difference between the groups was statistically significant ( P = 0.016). CONCLUSION These results show that the presence of a stent is associated with a worse outcome after ESWL for ureteric stones. Ureteric stents should still be used in cases of obstruction, when there is a risk of sepsis, and in patients with intolerable pain or deteriorating renal function. However, their use in patients offered ESWL for ureteric stones should be considered with caution. [ABSTRACT FROM AUTHOR]

The article assesses the laparoscopic nephroureterectomy (LNU) and endoscopic treatment for upper urinary tract transitional cell carcinoma (UUT-TCC). In LNU, the kidney and ureter are removed by either a retroperitoneal or a transperitoneal approach. The removal of the ureter is an important step for the whole procedure. The ureteroscopy management of UUT-TCC has resulted in a successful outcome in a significant proportion of patients.

Focuses on renal haemangiopericytoma (HPC). Pulmonary metastases from HPC; Uncontrolled proliferation of pericytes.